Javier Sanchez, MD
Clinical Cardiac Electrophysiology · Austin, TXNPI 1518942226
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,000 of the $50,368 with a category attached, or 65.5%. 21 manufacturers reported payments, led by Biosense Webster, Inc. at 32.7% of the total. Reporting peaked in 2023 at $18,737 and has fallen 67.4% since, to $6,110 in 2025.
Across 354 payments — averaging $142.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$16K
- Medical Device Business Services, Inc.$14K
- Boston Scientific$6K
- Medtronic$6K
- Abbott$2K
- Atricure, Inc.$2K
- plus $4K from 15 others
Across 13 payments — averaging $11,458 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cordis US CORP.$79K
- Cardiva Medical, Inc.$70K
What the payments were for
- Consulting fees$33,00066%
- Travel & lodging$1,4443%
- Food & beverage$15,92432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 19 | $16,448 |
| Medical Device Business Services, Inc. | 6 | $14,387 |
| Boston Scientific | 45 | $6,239 |
| Medtronic(2 entities) | 163 | $5,880 |
| Abbott | 59 | $2,222 |
| Atricure, Inc. | 17 | $1,528 |
| Impulse Dynamics (USA) Inc. | 8 | $1,024 |
| Cordis US CORP. | 2 | $599 |
| Abiomed | 3 | $481 |
| E.r. Squibb & Sons, L.L.C. | 17 | $361 |
| Johnson & Johnson | 2 | $217 |
| Edwards Lifesciences | 1 | $166 |
| Cvrx, Inc. | 1 | $148 |
| Cardiva Medical, Inc. | 3 | $142 |
| Cardiofocus, Inc. | 1 | $133 |
| Biosig Technologies, Inc. | 1 | $132 |
| Biotronik Inc. | 2 | $126 |
| Merit Medical Systems Inc | 1 | $64 |
| Johnson And Johnson International | 1 | $32 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Braemar Manufacturing, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$12,775
- FARAWAVE$3,750
- Carto 3$1,477
- Micra$950
- OPTIMIZER SMART SYSTEM$684
- Claria MRI$663
- OPTIMIZER$524
- MYNX CONTROL$500
- SYNERGY ABLATION SYSTEM$473
- ENSITE$421
- COBALT DR MRI SURESCAN$353
- Impella$343
- Farapulse$316
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$260
- XARELTO$217
- GALLANT$176
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$175
- WORKMATE CLARIS$169
- EnSite Precision Cardiac Mapping System$168
- INSPIRIS RESILIA aortic valve$166
How this compares
$50,368 in reported general payments places this provider in the 65th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 85 | $117,793 |
| XareltoRivaroxaban | 28 | $35,759 |
| MultaqDronedarone Hcl | 14 | $13,601 |
| Flecainide Acetate | 58 | $2,114 |
| Metoprolol Succinate | 97 | $1,293 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 45 | $899 |
| Potassium Chloride | 29 | $606 |
| SotalolSotalol Hcl | 17 | $373 |
| Metoprolol Tartrate | 36 | $286 |
| Amiodarone Hcl | 17 | $210 |
| Doxycycline Hyclate | 23 | $178 |
| Sucralfate | 15 | $148 |
| Furosemide | 24 | $70 |
| Pantoprazole Sodium | 14 | $34 |
| Carvedilol | 19 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $217 | $35,75928 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Austin
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Rodney HortonAustin$553K
- Robert CanbyAustin$224K
- Weeranun BodeAustin$178K
- David TschoppAustin$114K
- Mauricio HongAustin$79K
- Michael DelaughterBedford$1.6M
- Dale YooMcKinney$585K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.